NCT06181994 Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)
| NCT ID | NCT06181994 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Montefiore Medical Center |
| Condition | Chronic Subdural Hematoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2023-12-05 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2023-12-05 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This multi-center retrospective cohort study aims to investigate the real-world outcomes of chronic subdural hematoma treated with MMAE, including clinical effectiveness, recurrence rates, and safety profile.
Eligibility Criteria
Inclusion Criteria: * Consecutive adult patients (18 yrs. of age or older) * Endovascular embolization of middle meningeal artery using any embolization material: PVA particles; Onyx, nBCA glue; dimethyl sulfoxide, microcoils, PVA with microcoils Exclusion Criteria: * Endovascular embolization of middle meningeal artery using any other embolization material
Contact & Investigator
David Altschul, MD
PRINCIPAL INVESTIGATOR
Montefiore Medical Center
Frequently Asked Questions
Who can join the NCT06181994 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Subdural Hematoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06181994 currently recruiting?
Yes, NCT06181994 is actively recruiting participants. Contact the research team at muhammedamir.essibayi@einsteinmed.edu for enrollment information.
Where is the NCT06181994 trial being conducted?
This trial is being conducted at Coral Gables, United States, Jacksonville, United States, Orlando, United States, Chicago, United States and 11 additional locations.
Who is sponsoring the NCT06181994 clinical trial?
NCT06181994 is sponsored by Montefiore Medical Center. The principal investigator is David Altschul, MD at Montefiore Medical Center. The trial plans to enroll 5,000 participants.